Diagnostic management of clinically suspected acute pulmonary embolism.
Current diagnostic management of hemodynamically stable patients with clinically suspected acute pulmonary embolism (PE) consists of the accurate and rapid distinction between the approximate 20-25% of patients who have acute PE and require anticoagulant treatment, and the overall majority of patients who do not have the disease in question. Clinical outcome studies have demonstrated that, using algorithms with sequential diagnostic tests, PE can be safely ruled out in patients with a clinical probability indicating PE to be unlikely and a normal D-dimer test result. This obviates the need for additional radiological imaging tests in 20-40% of patients. CT pulmonary angiography (CTPA) has become the first line tool to confirm or exclude the diagnosis of PE in patients with a likely probability of PE or an elevated D-dimer blood concentration. While single-row-detector technology CTPA has a low sensitivity for PE and bilateral compression ultrasound (CUS) of the lower limbs is considered necessary to rule out PE, multi-row-detector CTPA is safe to exclude PE without the confirmatory use of CUS.